There are two fundamental ways of describing stenosis severity based on anatomic and physiological approaches.1 These anatomic and physiological methods are related but provide independent complementary data; each is essential for judging severity and regression or progression or for making clinical decisions and will be briefly reviewed.
Anatomic-Geometric Assessment of Coronary
Stenosis Severity The anatomic-geometric approach uses all of the x-ray-determined geometric dimensions of a stenosis, including percent narrowing, absolute diameter, and length effects. These dimensions are integrated throughout the length of narrowing with fluid dynamic equations to predict stenosis resistance,2-4 pressure-flow characteristics of the stenosis,56 or coronary flow reserve.7,8 The anatomic approach is principally an invasive method requiring coronary arteriography because there is From no current way of accurately defining stenosis geometry noninvasively.
Visual interpretations of coronary arteriograms are marked by such great interobserver and intraobserver variability that a comparison of arteriograms from different patients or at different times from the same patient are of limited value in assessing severity, changes in severity, or functional significance of coronary artery stenosis.' For clinical purposes, percent narrowing is commonly used. However, it is an incomplete approximation of the correct anatomic-geometric method for describing severity because it does not account for other important geometric characteristics of stenoses, such as length, absolute cross-sectional luminal area, shape, multiple lesions in series, or eccentric narrowing that may be worse in one view compared with another. 1-10 Absolute cross-sectional lumen area has been proposed as a measure of stenosis severity because it correlated with directly measured coronary flow reserve in the left anterior descending coronary artery.'1 However, this association was true only for the left anterior descending artery and did not apply to other coronary arteries for describing stenosis severity. It is not, therefore, an adequate solution.
In contrast with these incomplete approximations of stenosis severity, the validity of quantitative coronary arteriography for predicting the functional pressure-flow characteristics of stenoses has been demonstrated if all the dimensions of the lesion are taken into account, including relative percent narrowing, absolute luminal area, and integrated length effects. Because these multiple dimensions have cumulative hemodynamic effects and interact with each other, they have to be integrated into a single measure of severity for a given stenosis to be practically useful. The most appropriate is flow reserve derived from all geometric dimensions of a stenosis as a standardized, single integrated measure of its severity, reflecting the combined effects of percent narrowing, absolute diameter, and length under "standardized" hemodynamic conditions. Determination of stenosis flow reserve by this quan- Severity of defects on perfusion images (abnormal maximum perfusion: normal maximum perfusion) should thus be less affected by physiological changes than absolute flow reserve (maximum flow: rest flow), even if the latter could be measured perfectly, and probably explains the good correlation between perfusion defects by positron emission tomography and stenosis flow reserve by quantitative coronary arteriography,8,9 although this explanation was not recognized at the time of these studies.
The sensitivity and specificity of exercise thallium imaging in early literature was 80-90% in symptomatic patients. More recent studies report a lower specificity of 60-70% in symptomatic patients2526 and a sensitivity of 70-80% with a specificity of 50-60% in asymptomatic subjects. 27 One possible explanation for these changing reports is that earlier groups of study patients were those undergoing cardiac catheterization for clinical reasons and hence would have greater prevalence of, more advanced, and/or more readily detected coronary artery disease. In recent years, stress thallium imaging has been used as a diagnostic tool to determine cardiac catheterization need. Accordingly, the study patients more Optimum Noninvasive Methods (Perfusion Imaging) Relative maximum myocardial perfusion or regional perfusion reserve can be assessed by radionuclide imaging, echocardiography, nuclear magnetic resonance imaging, or computed tomographic scanning. The well-defined basic principles are a strong stimulus for increasing coronary flow, such as intravenous dipyridamole; a method for monitoring relative regional perfusion changes at high-flow conditions to detect or quantify regional differences attributed to coronary arterial narrowing; and whole heart three-dimensional imaging so that artifactual defects are not created or real defects missed because of interplane undersampling or changes in position of the heart in the field.8
All of the above methods suffer from the failure of their "signal" or output information to increase in proportion to flow at the high flows necessary for noninvasive diagnostic imaging of myocardial perfusion. For fast computed tomography, intravenously injected perfusion tracers produce an input function that has a time duration greater than coronary transit time,32 thereby causing the output signal to plateau as myocardial perfusion increases.33,34 Because this problem is a basic one regardless of the type of tracer, it also limits echocardiographic measurements of perfusion after intravenous injection of microbubbles. Because nuclear magnetic resonance signal intensity decreases markedly as flow velocity rises,35 the signal from such images enhanced by gadolinium also plateaus as coronary flow rises. 36, 37 It is, therefore, unsatisfactory for diagnostic perfutory procedures (i.e., appropriate x-ray views, calsion imaging at high flows. Radionuclide uptake also fails to increase proportionately as flow increases because offalling myocardial extraction at high flows. When this problem is combined with the limitations of planar imaging or single proton emission computed tomography because of depth-dependent resolution and lack of attenuation correction, the resulting images do not accurately reflect regional maximum perfusion. Consequently, they are not quantitative, which probably explains their suboptimal diagnostic accuracy.
Myocardial uptake of positron radiotracers for perfusion imaging also fails to increase proportionately with flow.38-43 However, image reconstruction techniques in positron emission tomography are better than those in single proton emission computed tomography because of coincidence counting and attenuation correction. Although limited by falling extraction of radiotracer at high flows, the signal from positron emission tomography for following relative maximum perfusion is significantly better than other imaging modalities. It has sufficient quantitative capacity to be of reliable clinical value. With positron emission tomography, the perfusion information is reasonably quantitative, and the sensitivity and specificity is high.8,919'45,46 Figure 2 shows an example of rest-dipyridamole perfusion images obtained with 13N ammonia of a patient with three-vessel coronary disease. Three-vessel disease is readily identified as is relative severity. Significant resting collateral flow is shown by an absolute fall in activity on the dipyridamole image compared with the rest image reflecting myocardial steal. Based on data like that shown in this example, I believe the optimal noninvasive method for identifying and assessing severity of coronary artery stenosis is positron emission tomography. When used with dipyridamole stress testing, it is sufficiently quantitative to show lack of regional flow increase or a flow decrease (marked impairment of flow reserve) and can be used to identify candidates for coronary angiographic study to determine their potential suitability for mechanical treatment.
Current Problems and Future Directions
There are some basic conceptual and practical problems with positron imaging and quantitative coronary arteriography. As ficient accuracy to use for clinical decisions or investigative purposes. It is theoretically well developed, validated experimentally, and has been demonstrated clinically useful. Therefore, it is optimal for defining stenosis severity invasively.
Positron imaging of the heart with either generatorproduced 82Rb, cyclotron-produced '3N ammonia, or '8F deoxyglucose is optimal for accurate noninvasive diagnosis of coronary artery disease in symptomatic or asymptomatic patients,8 8194546 for assessing physiological stenosis severity,8,18,47-49 for imaging myocardial infarction50-59 and determining myocardial viability,51-57 for assessing effects of interventions such as thrombolysis56 or percutaneous transluminal coronary angioplasty on coronary flow reserve60 or of bypass surgery on function and metabolism,54 or for following progression or regression of coronary artery disease during risk factor treatment,6' and for evaluating collateral function noninvasively.62 Positron imaging, therefore, provides a physiological or functional basis for specific therapeutic approaches in the management of heart disease, particularly silent or symptomatic heart disease, that was not previously possible.
Accurate noninvasive physiological (positron emission tomography) and invasive anatomic (quantitative coronary arteriography) definition of stenosis severity are complementary. Together, they provide a complete description of coronary artery narrowing. Each is becoming essential to clinical cardiology for two major reasons. The first reason is that modern cardiovascular medicine has powerful medical or mechanical interventions for coronary artery disease that can heal or harm patients in the face of currently inadequate methods for quantitating stenosis severity. The bases for deciding on complex advanced interventions and for assessing or following their effects are usually fairly subjective or qualitative and have changed little clinically over the last 25 years. These endpoints are primarily chest pain and visual evaluation of arteriograms, assisted by electrocardiographic and thallium imaging; all are of limited independent accuracy, especially in the asymptomatic patient, and are poorly related to stenosis severity.
The second reason for optimal quantitation of stenosis is the growing importance of silent coronary atherosclerosis. Coronary heart disease causes one third to one half of all deaths of people between the ages of 35 The community model of mass intervention for coronary atherosclerosis has been questioned as optimal compared with the medical model for intervention by risk factor control in specific individuals. 73 However, even assuming its effectiveness, the medical model of risk factor control is limited by risk factor analysis having a low sensitivity and specificity for identifying individuals with significant coronary artery disease. For example, of 40-55-year-old adult men with high cholesterol and blood pressure, two thirds remain well over the subsequent 25 years. 74 Therefore, major questions facing cardiologists are how to identify silent coronary artery disease in specific individuals, how to define its severity, how to decide objectively between medical and mechanical interventions, and how to assess the results. Because anginal pectoris correlates relatively poorly with stenosis severity and can be improved if not eliminated in many patients with medical therapy, what endpoints are used for deciding on mechanical intervention? How are the results assessed?
Although we hope to improve mortality and use it as an important endpoint, mortality is a remote, indirect measure of outcome in coronary atherosclerosis, providing no quantitative gradations, no causal interconnections, and no insight into mechanisms in circumstances where they are most needed medically. Based on data outlined here, the answers to these questions may be best provided by quantitative coronary arteriography and positron emission tomography because they offer optimal definition of anatomic and physiological severity of coronary artery stenosis by both noninvasive and invasive means. References 
